OvaScience, Intrexon Collaborate on OvaScience's OvaTure Technology for Infertility Treatments
OvaScience, (NASDAQ: OVAS) and Intrexon Corporation (NYSE: XON) today announced an agreement to access Intrexon's portfolio of
technologies to accelerate the development of OvaScience's OvaTure℠
technology platform. Separately, the companies established a Joint
Venture, called OvaXon, to combine their unique technology platforms to
create new applications for improving human and animal health.